SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : STEM -- StemCells, Inc. -- Ignore unavailable to you. Want to Upgrade?

To: Mike McFarland who wrote (213)2/25/1999 5:31:00 AM
From: Mike McFarland  Respond to of 805
 
Parkinson's Disease News
mediconsult.com

Nature Biotechnology
November 1998 Volume 16 Number 11 pp 1033 - 1039
Engraftable human neural stem cells respond
to development cues, replace neurons, and
express foreign genes
biotech.nature.com

By the way, the February issue of Nature Biotechnology
has a whole mess of interesting articles...I may have
to subscribe--anybody get this journal now? Like it?



To: Mike McFarland who wrote (213)2/25/1999 6:25:00 AM
From: WWS  Read Replies (1) | Respond to of 805
 
Mike, thanks for the reminder of CTII's patents in regards to methods and procedures of expanding human neural stem cells. Limiting factor is that these are currently preclinical in development and have yet to show their practicality. While the potential is there, these will take time and dollars to develop. Does company have the capacity, at such a low share price, to raise the resources needed to shepherd this development through to completion?


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News